Thinking of joining a study?

Register your interest

NCT03001180 | RECRUITING | Vascular Anomaly


Identification of Biomarkers for Patients with Vascular Anomalies
Sponsor:

Children's Hospital Medical Center, Cincinnati

Brief Summary:

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Condition or disease

Vascular Anomaly

Generalized Lymphatic Anomaly

Kaposiform Hemangioendothelioma

Kaposiform Lymphangiomatosis

Gorham-Stout Disease

Klippel Trenaunay syndrome

Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi

Detailed Description:

While vascular anomalies are rare diseases, they can be life-threatening and devastating to affected children and their families. Advances in diagnosis, monitoring and therapies will be significantly improved if non-invasive biomarkers that are sensitive and specific can be identified. Obtaining a tissue biopsy to help in diagnosis can actually worsen the disease and so identification of specific blood biomarkers is highly desirable. Studies will measure angiogenic factors in serum and plasma samples at baseline and on therapy. Tissue removed during surgical resection or blood removed prior to sclerotherapy will be used to obtain cells and tissue for the assessment of where biomarkers are coming from and to identify disease-causing pathways for new therapeutic targeting.

Study Type : OBSERVATIONAL
Estimated Enrollment : 1000 participants
Official Title : Identification of Biomarkers for Patients with Vascular Anomalies
Actual Study Start Date : 2015-04
Estimated Primary Completion Date : 2050-12
Estimated Study Completion Date : 2050-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 1 Day
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Any patient having labs drawn as standard of care will have blood drawn for the study if consented/ assented.
  • * All patients who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank.
Exclusion Criteria
  • * N/A

Identification of Biomarkers for Patients with Vascular Anomalies

Location Details

NCT03001180


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


TERMINATED

United States, Massachusetts

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

RECRUITING

United States, Ohio

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Loading...